Finally, because of relatively early preoperative stage, none of these patients received neoadjuvant therapy, and therefore the predictive role of Ki-67 in SCCE treated with neoadjuvant therapy and surgery remains unclear. This evidence concerns the gene MKI67 and cervical small cell carcinoma.